Internal Medicine, Cardiovascular Disease · San Juan, PR
NPI
1023217775
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Ponce de Leon 715, Edif. San Vicente-Hosp Auxilio Mutuo
San Juan, PR, 00919
Phone (787) 955-8886
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
625 services
Medicare patients, 2024
187
Average age 73
Drug cost, 2024
$1.5M
14,436 prescriptions
Company payments, 2025
$1,159
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo G Colacioppo Saavedra was code 99213 (office e&m - established), 138 times for 93 patients. In total Ricardo G Colacioppo Saavedra billed 625 services in 20 codes, and Medicare paid $38K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 138 | 93 | $60.92 | $8,406 |
| 93000 Electrocardiogram | Office | 115 | 105 | $9.92 | $1,141 |
| 99214 Office E&M - Established | Office | 69 | 42 | $92.72 | $6,398 |
| 93306 Echocardiography (TTE/TEE) | Office | 59 | 59 | $135.25 | $7,980 |
| 93306 Echocardiography (TTE/TEE) | Facility | 41 | 39 | $48.75 | $1,999 |
| 99203 Office E&M - New | Office | 29 | 29 | $65.18 | $1,890 |
| 99213 Office E&M - Established | Facility | 28 | 23 | $48.95 | $1,370 |
| 93018 Electrocardiogram | Facility | 21 | 21 | $10.09 | $212 |
| 93016 Electrocardiogram | Facility | 21 | 21 | $15.27 | $321 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $125.52 | $2,636 |
By year: 2022 $36K for 612 services; 2023 $41K for 643 services; 2024 $38K for 625 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo G Colacioppo Saavedra prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,682 prescriptions and refills. In total Ricardo G Colacioppo Saavedra wrote 14,436 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,682 | 2,720 | 356 | $15K |
| Metoprolol Succinate Generic | 1,049 | 1,666 | 205 | $14K |
| Amlodipine Besylate Generic | 1,011 | 1,650 | 229 | $4,971 |
| Rosuvastatin Calcium Generic | 929 | 1,652 | 220 | $10K |
| Losartan Potassium Generic | 890 | 1,501 | 196 | $8,508 |
| Ezetimibe Generic | 761 | 1,265 | 161 | $12K |
| Carvedilol Generic | 446 | 670 | 85 | $3,729 |
| Eliquis Apixaban | 444 | 547 | 100 | $325K |
| Candesartan Cilexetil Generic | 387 | 661 | 86 | $32K |
| Synthroid Levothyroxine Sodium | 380 | 563 | 92 | $25K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 269 | 480 | 57 | $3,822 |
| Clopidogrel Clopidogrel Bisulfate | 264 | 432 | 62 | $2,800 |
| Farxiga Dapagliflozin Propanediol | 240 | 304 | 47 | $176K |
| Lisinopril Generic | 235 | 349 | 43 | $1,127 |
| Furosemide Generic | 233 | 375 | 58 | $1,336 |
Brand drugs: - claims; generic drugs: 12,216 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricardo G Colacioppo Saavedra $1,159 ($1,159 in general payments such as food, travel and fees) from 13 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $168.
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $168 |
| Boston Scientific Corporation BSX | 2 | $160 |
| Novo Nordisk Inc NVO | 2 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $125 |
| Lilly USA, LLC LLY | 1 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| Amgen Inc. AMGN | 4 | $86.02 |
| Pbg Puerto Rico LLC | 3 | $72 |
| Bayer Puerto Rico Inc. BAYN.DE | 2 | $50 |
| Merck Sharp & Dohme LLC MRK | 2 | $46.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.